(Newswire.net — August 3, 2015) — We hear it on the news, and how there are 97 million Americans that have it according to a new book on the subject of diabetes. Insulin resistance has been identified as the fundamental issue in obesity. In addition, it is also considered the fundamental defect in Type 2 Diabetes with or without obesity. Insulin resistance is involved with vascular disease, renal and heart disease.
The link between sugar and insulin resistance is also well known, and this topic forms much of the discussions about sugar, especially high fructose corn syrup and agave. It is a hot topic about how these sugars are converted to fat and placed in the wrong places, like in the liver. We are learning better just how sugars are metabolized in the body. Fructose plays an important role, along with unhealthy fats (instead of the good ones). It turns out that it is the liver that metabolizes fructose, and lab studies with rats and mice have proven that when fructose arrives at the liver in sufficient high amounts and over a short period of time, the result is that the liver will convert much of it to fat. This then brings about insulin resistance, more obesity, less use of sugar inside cells where it is needed for energy, and cellular damage.
Researchers believe that insulin resistance may also be the underlying problem in cancer. Many researchers now agree that the Western diet and metabolic syndrome are related to cancer, obesity and Diabetes Type II. Research on insulin and IGF, a hormone called insulin-like growth factor, has increasingly revealed that they promote tumor growth.
It is believed that cancer cells need insulin and/or IGF for propagation. Curiously, insulin resistance causes our bodies to secrete more insulin, and this elevated insulin appears to be a common step in many cancers, especially breast and colon cancers. Insulinomas are already known to produce more insulin, and it is being discovered that cancers may be modulating the systems of the body including to produce more insulin.
Sugar Causes More Hunger and Overeating
Fructose comprises a large portion of sugar that we eat in our foods, and has been shown to promote overeating. This is due to the stealthy nature of fructose in our system and it’s ability to evade the body’s regulating hormones, such as ghrelin and leptin, to let us know when we are hungry and full. Leptin is a chemical signal that normally tells the brain that there is a enough calories on board the body and tells us to stop eating. While leptin is produced with the presence of glucose, it is not to fructose. The consumption of fructose has not been recognized by the body, and more food is eaten.
This situation is worsened because sugar and fructose consumption has increased dramatically since 1972. Review food packaging, and you will find out how many bad fats and forms of sugar are in foods.
Because high fructose corn syrup is extremely cheap, it is being used more and more. The bottom line is chronic fructose consumption can cause hypertension, inflammation, obesity and metabolic syndrome, and is linked to cancer.
Stay away from drinks that contained refined sugar and juices with high levels of fructose. Instead substitute these with water, ice tea without sweeteners, and other sources of liquids without the big dose of sugar. Try lemon slices in cold water, try teas that are herbal, and be creative.
About the Author
Dr. Buckman is the Chief Medical Officer of Viratech Corp, Viratech, Corp. (OTC: VIRA), a software company focusing on developing disruptor based applications in the communication broadcasting, work flow management, crowd sourced labor and biotechnology fields.
Dr. Buckman has over 39 years of Health Care Experience in a variety of areas of medicine, including research. Dr. Buckman has presented research, published articles and books in the field of medicine, and has given lectures at numerous hospitals and at Medical Conferences. He has numerous Medical Publications, including some number #1 Best Selling Kindle Books on Amazon on breast cancer, oncology, diabetes plus medical articles, and medical research. He was the first US Physician to be accepted into the European Group for Breast Cancer Screening after his research in this field was accepted for publication and presentation at their international conference in Cyprus.
During the last 35 years he has worked to advance a number of medical technologies with a focus on Non-Harmful early detection of disease, with a primary focus on Breast Cancer and Diabetes. His most recent Breast Cancer work was published at the International Cancer Conference and Forum 2010, in Seoul, Korea. He is currently serving on the Industry Advisory Board for the University of Pacific School of Engineering and Computer Science and a Visiting Professor. He has decades of hospital Medical Director experience and has served on over many hospital committees for 35 years, and has served as Medical Director or Associate Director at Multiple Institutions.